Roberto Sorio
Impact in
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
Papers in
- Oncology 52
- Cancer Treatment and Pharmacology 26
- Lung Cancer Research Studies 11
-
- Ovarian cancer diagnosis and treatment 43
- Co-authors
- Éric Pujade-Lauraine (9 shared papers)Felix Hilpert (7 shared papers)Mansoor Raza Mirza (6 shared papers)Petronella O. Witteveen (5 shared papers)Gunnar B. Kristensen (5 shared papers)Ignace Vergote (7 shared papers)Pauline Wimberger (5 shared papers)B. Weber (6 shared papers)
In The Last Decade
Roberto Sorio
123 papers receiving 3.7k citations
Roberto Sorio's Hit Papers
Peers
Comparison fields: 5 of 106
- Reproductive Medicine 1.4k
- Oncology 1.4k
- Obstetrics and Gynecology 273
- Cancer Research 457
- Pathology and Forensic Medicine 482
Countries citing papers authored by Roberto Sorio
This map shows the geographic impact of Roberto Sorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Sorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Sorio more than expected).
Fields of papers citing papers by Roberto Sorio
This network shows the impact of papers produced by Roberto Sorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Sorio. The network helps show where Roberto Sorio may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Sorio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial Hit paper breakdown → | 2014 | 1171 |
| 2 | 2013 | 162 | |
| 3 | 1996 | 148 | |
| 4 | 1998 | 148 | |
| 5 | 2014 | 124 | |
| 6 | 2012 | 111 | |
| 7 | 2012 | 88 | |
| 8 | 1995 | 78 | |
| 9 | 1995 | 78 | |
| 10 | 2017 | 67 | |
| 11 | 1996 | 61 | |
| 12 | 1997 | 61 | |
| 13 | 2001 | 51 | |
| 14 | 1996 | 51 | |
| 15 | 2015 | 45 | |
| 16 | 1997 | 42 | |
| 17 | 2015 | 40 | |
| 18 | 1999 | 38 | |
| 19 | 2012 | 38 | |
| 20 | 2011 | 37 |
About Roberto Sorio
Roberto Sorio is a scholar working on Oncology, Reproductive Medicine, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 129 papers that have together received 3.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (43 papers), Cancer Treatment and Pharmacology (26 papers), Lymphoma Diagnosis and Treatment (12 papers), Lung Cancer Research Studies (11 papers), Cancer therapeutics and mechanisms (9 papers), Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Reproductive Medicine (1.4k citations), Oncology (1.4k citations), Obstetrics and Gynecology (273 citations), Cancer Research (457 citations) and Pathology and Forensic Medicine (482 citations). Roberto Sorio has collaborated with scholars based in Italy, France and Belgium. Frequent co-authors include Éric Pujade-Lauraine, Felix Hilpert, Mansoor Raza Mirza, Petronella O. Witteveen, Gunnar B. Kristensen, Ignace Vergote, Pauline Wimberger, B. Weber, David T. Bollag and Ana Oaknin. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Chemotherapy and Pharmacology, International Journal of Gynecological Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.